ANGO vs SRE · rev $292.5M vs P/E 31, rev $13.70B
AngioDynamics Inc (ANGO) versus Sempra Energy (SRE) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
ANGO currently screens at market cap $378.5M. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Not investment advice. Open the ANGO and SRE stock pages for the full models.
Not investment advice.